Montpellier, France 8/11/14 ; Paris, France 8/12/14—Alpha MOS, which filed for bankruptcy last year (see IBO 12/15/13), has announced that publicly held French company DMS, a provider of diagnostic medical-imaging systems, plans to make an investment in the company as part of a capital increase that will also include current shareholders. The offering will take […]
Calendar-year second quarter revenues for major, publicly held analytical instrument companies showed steady growth, despite purchase delays in China and uneven academic spending. Combined quarterly revenues for seven businesses whose quarterly results are profiled on pages 9–11 grew 4.8%, or 4.4% on an organic basis. Illumina recorded double-digit sales growth, while revenues for Bio-Rad Laboratories […]
Company Announcements In May, QIAGEN cofounder Dr. Detlev Riesner stepped down from the Supervisory Board. Dr. Elaine Mardis, codirector of the Genome Institute at Washington University and the Robert E. and Louise F. Dunn Distinguished Professor of Medicine, was proposed as a new member. Endress+Hauser revenues rose over 7% in 2013 to €1.8 billion ($2.4 […]
Second quarter revenues for IBO’s Laboratory Instrument Sales Index grew 4.8%, 4.3% excluding currency, to $6,259 million. Organic sales growth was driven by strong results from HORIBA, Illumina and Thermo Fisher Scientific. Operating profit advanced 10.5% to $1,324 million. Operating margin expanded 70 basis points to 18.4% of sales. Modest growth estimates are included for […]
Tokyo, Japan 8/4/14; Sedgefield, UK 8/5/14—Publicly held Japanese firm ReproCELL, a supplier of iPSC-derived products, and media and reagents for cell culture, has acquired UK-based Reinnervate and US-based BioServe Biotechnologies for an undisclosed amount. Reinnervate provides 3-D cell-culture products. BioServe supplies human tissue and other biological samples. “The ReproCELL group of companies now offers products […]
Purmerend, Amsterdam 7/1/14—Midmarket buyout firm AAC Capital has acquired a majority interest in Hobré Instruments from Parcom Capital. Hobré’s management team has also invested in the firm. Hobré designs and manufactures online analyzers, sample systems and turnkey systems for the oil and gas, and process industries. The company has annual revenues of €20 million ($27 […]
Bergisch Gladbach, Germany 8/14/14—Miltenyi Biotech, a provider of products and services for biomedical research and cellular therapy, has acquired Lentigen’s lentiviral-vector–manufacturing business and related assets, including intellectual property and process technologies. The purchase price was not disclosed. “It is our goal at Miltenyi Biotec to become the major supplier of lentiviral vectors for cell and […]
Berwyn, PA 8/5/14—AMETEK has purchased Amptek, a provider of x-ray detectors for XRF systems, electronics for nuclear and spaceflight instruments, and gamma-ray detectors. Financial details were not provided. Amptek has annual revenues of $30 million. “Its products and technology nicely complement our existing materials-analysis capabilities,” stated AMETEK Chairman and CEO Frank S. Hermance. “They also […]
Jena, Germany 8/13/14; Jena, Germany 8/14/14—Analytik Jena has agreed to acquire Bruker’s ICP-MS business and assets (see IBO 7/31/14) for an undisclosed amount. The business generated $12 million in revenues in 2013. “With the acquisition of the ICP-MS business from Bruker, we expect to close an important technological gap and will be in position to […]
The Dow Jones Industrial Average and S&P 500 reached record trading levels in early July due to constructive economic data, including growing consumer confidence and better-than-expected US GDP growth. Following a revised 2.1% decline in the first quarter, advance estimates for the second quarter GDP growth came in at a robust 4.0%. However, equity gains […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
